Pfizer and Strides Arcolab to Collaborate on Generic Products

Pfizer and Strides Arcolab have announced a collaboration, wherein Pfizer will commercialize off-patent sterile injectable and oral products in the US through its Established Products Business Unit.

These finished dosage form products will be licensed and supplied by Strides and Onco Laboratories and Onco Therapies, two joint ventures between Strides and Aspen, South Africa, in which each has a 50 percent ownership interest.

The first of the products that are commercialized under this collaboration are expected to be launched in 2010.